Similar articles

• The entry of ivermectin and suramin into Onchocerca ochengi nodules.

  Cross HF, Bronsvoort BM, Wahl G, Renz A, Achu-Kwi D, Trees AJ. Cross HF, et al. Ann Trop Med Parasitol. 1997 Jun;91(4):393-401. doi: 10.1080/00034989761012. Ann Trop Med Parasitol. 1997. PMID: 9290846
• Clinical pharmacology looks at tropical medicine.

  Breckenridge A, Orme M, Edwards G. Breckenridge A, et al. Trans R Soc Trop Med Hyg. 1987;81(4):529-33. doi: 10.1016/0035-9203(87)90394-4. Trans R Soc Trop Med Hyg. 1987. PMID: 3445331 No abstract available.
• [Senegalese experience with the efficacy of ivermectin (MK 933) in the treatment of human onchocerciasis (double-blind comparative study with diethylcarbamazine citrate) (DEC.C)].

  Diop Mar I, Diallo S, Diallo JS, Ndir O, Badiane S. Diop Mar I, et al. Bull Acad Natl Med. 1986 Jan;170(1):149-55. Bull Acad Natl Med. 1986. PMID: 3527347 Clinical Trial. French. No abstract available.
• Antifilarials and their mode of action.

  Subrahmanyam D. Subrahmanyam D. Ciba Found Symp. 1987;127:246-64. doi: 10.1002/9780470513446.ch17. Ciba Found Symp. 1987. PMID: 3297557 Review.
• [Chemotherapeutic problems in onchocerciasis].

  Rivas Alcalá AR, Ricárdez Esquinca JR. Rivas Alcalá AR, et al. Bol Chil Parasitol. 1988 Jul-Dec;43(3-4):57-61. Bol Chil Parasitol. 1988. PMID: 3077746 Review. Spanish. No abstract available.